Total Funding
39
5
Total FundingVenture - Series Unknown raised
Growth Score
-5 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
802068
Synthonics is a privately-held specialty pharmaceutical company with a focus on metal coordination chemistry.
- John Tinkham: CEO, Former General Counsel and Business Dev Director
About the Company
Synthonics is a privately-held specialty pharmaceutical company that focuses on the discovery and development of patentable drugs that incorporate proprietary metal coordination chemistry. It binds metals to known pharmaceutical agents to create new products that are better absorbed and thus have greater therapeutic benefits than their
predecessors.
